Health Checkup Market

Health Check-up Market Size

The global health check-up market size was valued at USD 57.4 billion in 2024 and is expected to exhibit growth at a CAGR of 6.6% from 2025 to 2034 period. The number of cases related to cancer, diabetes, and cardiovascular diseases is consistently increasing.

For example, according to the World Cancer Research Fund International, there were about 18.1 million cases of cancer all over the globe in 2020. These disorders when unchecked are burdensome and problematic. Hence, regular health check-ups play a crucial part in such situations as they allow for capture and management of these diseases at preemptive stages. Advancements in technology, an aging population, initiatives and policies made by the government in the healthcare sector greatly contribute towards the health checkup market.

Moreover, public authorities in several nations are formulating health strategies which aim at promoting preventive health care. This is done by providing regular health examinations which help in dealing with the economic implications caused by advanced-stage diseases. Also, many companies have started to provide employee wellness programs which include regular health examinations. These programs are intended to improve the health and reduce absenteeism of employees to increase productivity. Therefore, all these factors are likely to contribute towards the growth of the market during the forecast period.

A health check-up is also referred to as a health examination and it is an assessment of an individual’s health status by an expert. It is usually carried out by a healthcare provider, which may include a physician, a nurse or any other authorized personnel. The main aim of a health checkup is to appraise the health condition of a person, note any alarming health issues and offer appropriate preventative measures.

Health Check-up Market Trends

The growth of the healthcare industry is significantly driven by the adoption of digital technologies, telemedicine, and home-care services. The adoption of digital technologies as well as telemedicine is accelerating not just the efficacy of health check-ups, but also the general paradigm of health care from being reactive focused to patient centered and preventive.

• The advancement of technology allows services to be provided digitally from a distant place. For instance, telehealth technology permits patients to communicate with health specialists for a routine check-up while staying at home.
  
• With the advent of wearable medical tools and health tracking technologies, patients can now take an active role in managing their healthcare. These devices can automatically and continuously monitor vital metrics like blood pressure, glucose, and pulse.
  
• The whole system is now integrated into a single network where patients, telemedicine physicians, and all other diagnostic departments form one family. Such systems frequently allow patients to schedule virtual checkups, pull their medical card presets with a finger, or ask for advice on other health-related issues.
  

Health Check-up Market Analysis

In 2021, the global market was valued at USD 44 billion. The following year, it saw a slight increase to USD 49.2 billion, and by 2023, the market further climbed to USD 53.3 billion. Based on type, the market is categorized into general health check-up, specialized health check-up, preventive health check-up, and routine and wellness health check-up. The general health check-up segment is expected to drive business growth and expand at a CAGR of 6.5%, reaching over USD 41.3 billion by 2034.

• Severe health complications can be prevented with regular health check-ups, allowing for timely intervention and management. Early identification can prevent the progression of diseases and improve treatment outcomes.
  
• A good number of medical aid packages motivate, or in some cases, compel, their clients to undergo periodic medical examinations. This is done so as to prevent risks or in order to mitigate or compensate the burden on the coverage allocated under the policy.
  
• With advancing age, the probability of an individual suffering from specific ailments becomes greater. Routine check-ups are now essential for monitoring health shifts due to aging and for managing problems related to senescence.
  

Based on test type, the health check-up market is segmented as complete blood count test, blood glucose test, kidney function test, bone profile test, electrolyte test, liver function test, lipid profile test, cardiac biomarkers, hormones & vitamins, tumor markers, and other test types. The complete blood count test segment is expected to drive business growth and expand at a CAGR of 6.2%, reaching over USD 24.1 billion by 2034.

• The CBC test gives an details about the types and count of blood cells, red blood cells, white blood cells, and platelets. CBC tests also contain the hemoglobin and hematocrit parameters which are important for evaluating a person's nutritional condition and presence of iron deficiency anemia. It assists healthcare professionals with evaluating multiple aspects of a person’s well-being.
  
• CBC tests can be used to detect infections or inflammatory conditions from the changes in the white blood cell count. This is important when assessing the infection and its subsequent management.
  
• Abnormal blood cell counts may be suggestive of other medical problems such as anemia, infection, leukemia, or disorders of blood clotting. These conditions can be diagnosed early and managed appropriately with the aid of CBC tests.
  

Based on sample type, the health check-up market is categorized into blood, urine, saliva, and other sample types. The blood segment is expected to drive business growth and expand at a CAGR of 6.7%, reaching over USD 79.1 billion by 2034.

• Blood tests provide tremendous information about a person’s health, from blood cell counts to hormones, metabolism, and biochemical markers. These tests are insightful because, with the results, the organs or systems within the body that require more attention can be determined.
  
• Proteins, glucose, cholesterol, and enzymes are just few of the many analytes that can be measured during a blood test. The wide variety of options helps in diagnosing and treating different medical problems, some of which are still not curable in the medical field.
  
• There are also more specific advanced blood tests for certain conditions and risk factors, including many genetic tests, tumor markers, and specific antibody assays. Each of these adds more knowledge that is important for personalized medicine. Therefore, all such reasons account for the growth of the blood segment in the focus of analysis.
  

Based on panel type, the health check-up market is bifurcated into multi-test panels and single-test panels. The multi-test panels segment is expected to drive business growth and expand at a CAGR of 6.7%, reaching over USD 84.8 billion by 2034.

• Doing several examinations separately can be costly and time-consuming. Using multi-panel tests as a diagnostic tool reduces the number of samples and tests needed. This improves efficiency and lowers costs for both providers and patients.
  
• Multi-panel tests provide a wider scope of health information by assessing several analytes at the same time. This consolidation further enhances the evaluation of various bodily systems, thus giving a great deal of information with respect to health condition.
  
• The tests are more beneficial in screening patients for various diseases at once like diabetes, cardiovascular disease, liver and kidney problems. This increases the scope of their use in general health screening programs.
  

Based on service provider, the health check-up market is fragmented into hospital-based laboratories, standalone laboratories, central laboratories, ambulatory care centers, and other service providers. The hospital-based laboratories segment dominated the market with a revenue share of 54.1% in 2024.

• A variety of tests and screenings are also a portion of the diagnostic services offered by hospital-based laboratories. This enables people to have complete health examinations which address numerous components of their health at one single place.
  
• In addition, most hospital-based laboratories are connected to other clinical services within the hospital. This setup makes it easier for professionals to communicate with each other, ensuring that test results are sent to the right specialists for further analysis and action.
  
• Hospitals are also equipped to handle emergencies and critical care cases. Doing a health check-up in a hospital allows for immediate attention to an emergency situation when there are unexpected health problems that require immediate attention during the evaluation.
  

U.S. health check-up market accounted for USD 17.9 billion in 2023 and USD 19.1 billion in 2024 and is anticipated to grow at a CAGR of 5.7% between 2025 to 2034 period.

• The U.S. preventive healthcare services market is expected to grow significantly due to a general increase in awareness about taking proactive steps to maintain health. There is an increase in check-up visits by patients and doctors because of the rising rates of diabetes, hypertension, and heart-related complications
  
• Routine check-ups are on the increase due to the elderly population which requires frequent and more thorough examination. Additionally, the progressive nature of diagnostic devices has made it easier for the patients to undergo health assessments as the procedures are performed with greater precision and lower pain, thus increasing the number of participants.
  
• In addition, market growth has been driven by employer-sponsored health programs as well as incentive plans for regular check-ups which have encouraged employees to monitor their health constantly. At the same time, the growing use of telemedicine and mobile health clinics has made health check-ups more accessible in remote and underserved areas. Policies like the Affordable Care Act (ACA), which provide coverage for preventive services, have made essential routine screenings available to a larger population.
  
• The COVID-19 pandemic has highlighted the importance of regular health assessments to monitor individual health and wellness. This has boosted preventive healthcare activities. With the increasing focus on health and wellness, the U.S. market is expected to grow steadily in the coming years.
  

In the Europe health check-up market, UK is projected to grow remarkably in the coming years.

• Multi-functional industry drivers such government funding, increasing chronic illnesses, and growing health consciousness are predicted to accelerate the growth of the UK market in the forthcoming years. The National Health Service (NHS) has been expanding its preventive health strategy through initiatives like the NHS Health Check program, which provides free screenings for cardiovascular disorders, diabetes, and kidney diseases for persons aged 40 to 74.
  
• Further, the increase in lifestyle diseases, for instance, obesity and hypertension, is also propelling the demand for routine health checks by patients prompted by the need for early diagnosis and treatment. Another important consideration is the aging population in the UK, who require regular evaluations to control a plethora of ailments associated with old age.
  
• The private sector is also contributing to this growth. Leading diagnostic providers are offering comprehensive screening packages. These include genetic and cancer screenings, as well as full-body evaluations for different health conditions.
  
• The adoption of digital health technologies, like AI diagnostics and telemedicine, has made health check-ups more accessible and efficient. In addition, these days there is more emphasis on workforce wellness programs as companies provide employee health check-ups in order to boost work absenteeism and productivity.
  
• The UK is strategically positioned as a growth leader in the European market due to the rise in disposable income and increased cognizance about tailored preventive care.
  

China holds a dominant position in the Asia Pacific health check-up market.

• China is using several factors to gain an advantage in the Asia Pacific health checkup market. The need for preventive healthcare services is increasing as the elderly population in China grows, along with chronic illnesses like diabetes, cardiovascular diseases, and cancer. 
  
• Additionally, government programs like "Healthy China 2030" encourage early disease detection and promote health screenings. Economic factors, such as the growing middle class, higher disposable incomes, and increased focus on health, are also supporting the market. 
  
• In addition, the vast network of hospitals, and private health check-up institutions ensures that there are enough facilities for the ever-increasing demand of screening services. The growth of these services being fueled by newer technologies such as AI, telemedicine, and precision medicine enables improved efficiency and accuracy of health check-ups.
  
• Corporates also help bulster the market as they incorporate wellness programs for their employees. The addition of insurance to health check-ups has also increased affordability. Lastly, an influx of tourists coming for high quality, yet inexpensive health check-ups boost the medical tourism industry and allows China to further strengthen its leadership.
  

Health Check-up Market Share

Numerous global companies compete in this field for better test panels and kits, thus making the health check-up industry competitive. Significant market competitors, Quest Diagnostics Incorporated, Eurofins Scientific, Exact Sciences Corporation, Quidel Corporation, and others, hold a more than 40% share in this market. These companies are working towards increasing their market presence through new product introduction, partnership, or other strategic moves.

Health Check-up Market Companies

Prominent players operating in the health check-up industry include:

• ARUP Laboratories
• Cerba Healthcare
• eurofins
• Exact Sciences
• GRAIL
• INNOVA
• labcorp
• natera
• OPKO
• Q2 Solutions
• Quest Diagnostics
• Sonic Healthcare
• SYNLAB
• Trinity Biotech
• UNILABS
  
• GRAIL - Early detection of cancer through liquid biopsy technology. A pioneer of multi-cancer early detection (MCED) tests, most notably the Galleri test, which seeks and identifies cancer signals in blood samples. It uses next-generation sequencing (NGS) and AI-powered analytics to locate cancers of over 50 types during their early stages. The company uses aggressive advertising towards healthcare practices and insurance firms to expand its reach.
  
• INNOVA Medical Group - Swift diagnostics and extensive testing techniques. A world leader in point-of-care diagnostics, specializing in the development and distribution of rapid tests for infectious diseases, including antigen and antibody tests. The company has knowledge and experience in mass testing programs for COVID-19 using rapid testing kits that have been widely adopted across the globe. Its dependable supply chain and manufacturing flexibility allow rapid scale-up of production to meet sudden high demand.
  

Health Check-up Industry News:

• In November 2023, Universal DX announced a strategic partnership with Quest Diagnostics, a U.S.-based supplier of diagnostic information services, to improve colorectal cancer screening in the U.S. Under the commercial agreement, Quest plans to perform and provide clinical laboratory services to providers and patients in the U.S. using UDX's Signal-C, an advanced colorectal cancer screening blood test.
  
• In September 2023, GRAIL, LLC, and Point32Health announced the expansion of their pilot project to offer GRAIL's groundbreaking Galleri multi-cancer early detection screening test. This development could create new opportunities for the company and strengthen its presence in the industry.
  

The health check-up market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• General health check-up
• Routine and wellness health check-up
• Specialized health check-up
• Preventive health check-up

Market, By Test Type

• Complete blood count test
• Blood glucose test
• Electrolyte test
• Lipid profile test
• Hormones & vitamins
• Tumor markers
• Liver function test
• Cardiac biomarkers
• Kidney function test
• Bone profile test
• Other test types

Market, By Sample Type

• Blood
• Urine
• Saliva
• Other sample types

Market, By Panel Type

• Multi-test panels
• Single-test panels

Market, By Service Provider

• Hospital-based laboratories
• Standalone laboratories
• Ambulatory care centers
• Central laboratories
• Other service providers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE